1 active not recruiting, 1 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Dengue With Warning Signs: new trials by email Literature Review of Dengue With Warning Signs trials Research Report on Dengue With Warning Signs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anakinra in Dengue With Hyperinflammation ( AnaDen ) Placebo, Anakinra - Dengue, Dengue With Warning Signs | Phase 2 | Active not recruiting | Oxford University Clinical Research Unit, Vietnam | 160 | 2023-01-02 | 2026-01-06 |
| Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients Montelukast, Placebo - Dengue, Dengue With Warning Signs | Phase 2 / Phase 3 | Completed | Phramongkutklao College of Medicine and Hospital | 358 | 2021-01-15 | 2023-07-18 |
Dengue (2) · Severe Dengue (2) · Cytokine Release Syndrome (1) · Macrophage Activation Syndrome (1)
Arbovirus Infections (2) · Flaviviridae Infections (2) · Flavivirus Infections (2) · Hemorrhagic Fevers, Viral (2) · Infections (2) · Mosquito-Borne Diseases (2) · RNA Virus Infections (2) · Vector Borne Diseases (2) · Virus Diseases (2) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Inflammation (1) · Lymphoproliferative Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Interleukin 1 Receptor Antagonist Protein (1) · montelukast (1)
Oxford University Clinical Research Unit, Vietnam (1) · Phramongkutklao College of Medicine and Hospital (1)
Thailand (1) · Vietnam (1)
Sophie Yacoub (1) · Worapong Nasomsong, MD (1) · Worayon Chuerboonchai, MD (1)